Search research articles
Contact Us
Filters
Showing results (11-20 of 76) with videos related to
Page
of 8
Sort By:
Immunotargets and Therapy
|
June 30, 2021
VISTA: A Promising Target for Cancer Immunotherapy?
Marco Tagliamento, Elisa Agostinetto, Roberto Borea, et al.
European Journal of Clinical Investigation
|
March 4, 2021
CDK4/6 and PI3K inhibitors: A new promise for patients with HER2-positive breast cancer
Elisa Agostinetto, Véronique Debien, Guilherme Nader Marta, et al.
Critical Reviews in Oncology/Hematology
|
March 2, 2019
Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy?
Rosalba Torrisi, Monica Zuradelli, Elisa Agostinetto, et al.
Journal of Clinical Medicine
|
March 11, 2023
Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib
Flavia Jacobs, Elisa Agostinetto, Alessandra Solferino, et al.
Critical Reviews in Oncology/Hematology
|
March 5, 2021
Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?
Rosalba Torrisi, Emilia Marrazzo, Elisa Agostinetto, et al.
Cancers
|
July 2, 2021
HER2-Low Breast Cancer: Molecular Characteristics and Prognosis
Elisa Agostinetto, Mattia Rediti, Danai Fimereli, et al.
Future Oncology (London, England)
|
August 23, 2023
DECRESCENDO: de-escalating chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancer
Véronique Debien, Virginie Adam, Elisabeth Coart, et al.
Future Oncology (London, England)
|
September 13, 2016
Caring for cancer survivors: perspectives of oncologists, general practitioners and patients in Italy
Fabio Puglisi, Elisa Agostinetto, Lorenzo Gerratana, et al.
International Journal of Molecular Sciences
|
April 30, 2021
Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models
Alessio Gerussi, Ambra Natalini, Fabrizio Antonangeli, et al.
Breast Care (Basel, Switzerland)
|
January 2, 2023
HER2-Low Breast Cancer: Where Are We?
Chiara Molinelli, Flavia Jacobs, Caterina Marchiò, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 76) with videos related to
Sort By:
Page
of 8
Immunotargets and Therapy
|
June 30, 2021
VISTA: A Promising Target for Cancer Immunotherapy?
Marco Tagliamento, Elisa Agostinetto, Roberto Borea, et al.
European Journal of Clinical Investigation
|
March 4, 2021
CDK4/6 and PI3K inhibitors: A new promise for patients with HER2-positive breast cancer
Elisa Agostinetto, Véronique Debien, Guilherme Nader Marta, et al.
Critical Reviews in Oncology/Hematology
|
March 2, 2019
Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy?
Rosalba Torrisi, Monica Zuradelli, Elisa Agostinetto, et al.
Journal of Clinical Medicine
|
March 11, 2023
Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib
Flavia Jacobs, Elisa Agostinetto, Alessandra Solferino, et al.
Critical Reviews in Oncology/Hematology
|
March 5, 2021
Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?
Rosalba Torrisi, Emilia Marrazzo, Elisa Agostinetto, et al.
Cancers
|
July 2, 2021
HER2-Low Breast Cancer: Molecular Characteristics and Prognosis
Elisa Agostinetto, Mattia Rediti, Danai Fimereli, et al.
Future Oncology (London, England)
|
August 23, 2023
DECRESCENDO: de-escalating chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancer
Véronique Debien, Virginie Adam, Elisabeth Coart, et al.
Future Oncology (London, England)
|
September 13, 2016
Caring for cancer survivors: perspectives of oncologists, general practitioners and patients in Italy
Fabio Puglisi, Elisa Agostinetto, Lorenzo Gerratana, et al.
International Journal of Molecular Sciences
|
April 30, 2021
Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models
Alessio Gerussi, Ambra Natalini, Fabrizio Antonangeli, et al.
Breast Care (Basel, Switzerland)
|
January 2, 2023
HER2-Low Breast Cancer: Where Are We?
Chiara Molinelli, Flavia Jacobs, Caterina Marchiò, et al.
Page
of 8